FMC Corporation 2007 Annual Report (10-K) Summary
Business Context and Reporting Period
Company: FMC Corporation
Reporting Period: Fiscal year ended December 31, 2007
Business Overview: FMC is a diversified, global chemical company operating in three segments: Agricultural Products (insecticides, herbicides), Specialty Chemicals (BioPolymer food/pharma ingredients, lithium), and Industrial Chemicals (soda ash, peroxygens, phosphorus).
Corporate Action: A two-for-one stock split was effected on September 13, 2007. All share and per-share data in this report are adjusted to reflect the split.
Key Financial Metrics (2007)
| Metric | 2007 Value | 2006 Value |
|---|---|---|
| Revenue | $2,632.9 million | $2,345.9 million |
| Net Income | $132.4 million | $131.3 million |
| Diluted EPS | $1.71 | $1.66 |
| Operating Cash Flow | $314.7 million | $307.2 million |
| Total Assets | $2,733.4 million | $2,740.7 million |
| Total Debt | $545.2 million | $629.7 million |
| Long-Term Debt | $497.3 million | $576.0 million |
| Segment Operating Profit | $442.2 million | $365.3 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenue increased 12.2% to $2.63 billion, driven by growth in all segments (Agricultural +16%, Specialty +11%, Industrial +10%).
- Profitability: Net income remained relatively flat (+0.8%) despite a 21% increase in segment operating profit. This was due to significant non-operating charges and restructuring costs.
- Restructuring Charges: Total restructuring and other charges were $162.9 million in 2007, compared to $74.8 million in 2006. Major items included:
- $104.9 million for the phase-out of the Baltimore, Maryland agricultural facility.
- $22.5 million for a legal settlement with Solutia.
- $12.2 million for asset abandonment at the Foret subsidiary.
- Discontinued Operations: Recorded a loss of $24.3 million (vs. $12.8 million loss in 2006), primarily due to environmental and legal reserves at former defense sites.
- Debt Reduction: Total debt decreased by approximately $84.5 million, primarily due to scheduled repayments and partial repayment of the European Credit Agreement.
Guidance, Outlook, and Risks
2008 Outlook: Management expects continued growth in revenue and earnings. Drivers include higher soda ash prices, volume growth in BioPolymer and lithium, and a healthy global agribusiness economy. Profit growth is expected to be partially offset by higher raw material and energy costs.
Key Risks and Contingencies:
- Regulatory: Ongoing regulatory reviews of key products (e.g., carbofuran) in the U.S. and EU. The EU has not renewed approvals for carbofuran, carbosulfan, and cadusafos, leading to ceased sales in the region, though litigation is ongoing.
- Environmental: Net environmental reserve was $169.8 million. Reasonably possible loss contingencies may exceed accrued amounts by approximately $75 million.
- Legal: Approximately 29,000 asbestos claims pending. A $25 million European Commission fine regarding hydrogen peroxide competition law (recorded in 2006) is under appeal.
- Market: Sensitivity to energy costs (approx. 13% of cost of sales) and foreign exchange rates (Euro, Chinese Yuan, Brazilian Real).
Investor Verification Checklist
- Restructuring Execution: Verify the timeline and cost realization of the Baltimore facility phase-out and the Foret asset abandonment.
- Regulatory Outcomes: Monitor the status of the EPA Scientific Advisory Panel meeting regarding carbofuran and the outcome of EU litigation.
- Environmental Reserves: Review the adequacy of the $169.8 million environmental reserve against the disclosed $75 million in reasonably possible additional losses.
- Debt Covenants: Confirm continued compliance with leverage and interest coverage covenants under the new Domestic Credit Agreement ($600 million facility).
- Share Repurchases: Track progress on the $250 million share repurchase program (approx. $160 million remaining as of year-end).